Search

Your search keyword '"Kawalia, A"' showing total 222 results

Search Constraints

Start Over You searched for: Author "Kawalia, A" Remove constraint Author: "Kawalia, A"
222 results on '"Kawalia, A"'

Search Results

1. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

2. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

3. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

4. The genomic and clinical landscape of fetal akinesia

5. Correction: The genomic and clinical landscape of fetal akinesia

6. Human exome and mouse embryonic expression data implicate ZFHX3, TRPS1, and CHD7 in human esophageal atresia.

7. Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

9. Rare gene deletions in genetic generalized and Rolandic epilepsies.

11. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

12. Recurrent and Prolonged Infections in a Child with a Homozygous IFIH1 Nonsense Mutation

13. Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes

14. Mutations of KIF14 cause primary microcephaly by impairing cytokinesis

15. Comprehensive molecular analysis of 61 Egyptian families with hereditary nonsyndromic hearing loss

16. Leveraging the power of high performance computing for next generation sequencing data analysis: tricks and twists from a high throughput exome workflow.

17. The genomic and clinical landscape of fetal akinesia

18. Correction: The genomic and clinical landscape of fetal akinesia

19. Rare variants in γ-aminobutyric acid type A receptor genes in rolandic epilepsy and related syndromes

20. SORL1 ‐variant carriers in ADES‐ADSP: A higher level of variant pathogenicity associates with earlier age at onset of Alzheimer's disease

21. Exome sequencing identifies three novel AD‐associated genes

22. DEPDC5 mutations in genetic focal epilepsies of childhood

23. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as novel risk factors for Alzheimer’s Disease

24. Comprehensive molecular analysis of 61 Egyptian families with hereditary nonsyndromic hearing loss

25. Human exome and mouse embryonic expression data implicate ZFHX3, TRPS1, and CHD7 in human esophageal atresia

26. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

27. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

28. Author response for 'Comprehensive molecular analysis of 61 Egyptian families with hereditary nonsyndromic hearing loss'

29. Exome sequencing identifies novel AD-associated genes

30. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

31. Comprehensive molecular analysis of 61 Egyptian families with hereditary nonsyndromic hearing loss

32. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

33. Human exome and mouse embryonic expression data implicateZFHX3,TRPS1, andCHD7in human esophageal atresia

34. A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2

35. Human exome and mouse embryonic expression data implicate ZFHX3, TRPS1, and CHD7 in human esophageal atresia

36. Human exome and mouse embryonic expression data implicate ZFHX3, TRPS1, and CHD7 in human esophageal atresia

37. Comprehensive molecular analysis of 61 Egyptian families with hereditary nonsyndromic hearing loss

38. Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer's disease.

39. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

40. Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

41. Novel mutations in

42. Die genomische Ätiologie fetaler Akinesie

43. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing (vol 51, pg 414, 2019)

44. Nat Genet

45. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

46. Polygenic risk and hazard scores for Alzheimer's disease prediction

47. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

48. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing

49. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

50. Novel mutations in SLC6A5 with benign course in hyperekplexia

Catalog

Books, media, physical & digital resources